文献速递慢性肾脏病血液净化与透析

糖化白蛋白与HbA1c在糖尿病合并CKD患者血糖控制评估中的比较

Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients With Diabetes and CKD.
PubMed 文献 · Kidney Int Rep · 2017-11-21

该Meta分析纳入24项研究共3928例患者,比较糖化白蛋白(GA)与糖化血红蛋白(HbA1c)与平均血糖(AG)的相关性。结果显示在CKD早期两者相关性无显著差异(P>0.05),但在CKD晚期GA与AG的相关性(R=0.57)显著优于HbA1c(R=0.49,P=0.0001),提示GA在晚期CKD患者中评估血糖控制更优。

要点

  • CKD早期GA与HbA1c和平均血糖相关性无显著差异
  • CKD晚期GA与平均血糖相关性显著优于HbA1c
  • 晚期CKD糖尿病患者可考虑用GA替代HbA1c评估血糖

核心结论

  • 在糖尿病合并晚期CKD患者中,GA在评估血糖控制方面优于HbA1c。

研究设计与样本

  • 系统检索PubMed、Embase、Web of Science、Scopus、Cochrane Library和MEDLINE至2017年7月,纳入24项研究共3928例患者,使用RevMan5.3和Stata12.0进行Meta分析。

主要发现

  • CKD早期(1-3期)GA与AG的汇总R为0.61(95%CI=0.49-0.73),HbA1c与AG的汇总R为0.71(95%CI=0.55-0.87),两者差异无统计学意义(P>0.05)。
  • CKD晚期(4-5期包括透析)GA与AG的汇总R为0.57(95%CI=0.52-0.62),HbA1c与AG的汇总R为0.49(95%CI=0.45-0.52),差异有统计学意义(P=0.0001)。

关键数值与推荐

  • CKD早期GA与AG的汇总R=0.61(95%CI=0.49-0.73),HbA1c与AG的汇总R=0.71(95%CI=0.55-0.87),P>0.05。
  • CKD晚期GA与AG的汇总R=0.57(95%CI=0.52-0.62),HbA1c与AG的汇总R=0.49(95%CI=0.45-0.52),P=0.0001。

临床怎么用

  • 对于糖尿病合并晚期CKD(4-5期包括透析)患者,可优先考虑使用GA而非HbA1c评估血糖控制。
  • 对于CKD早期患者,GA与HbA1c评估血糖控制效能相当,可根据临床情况选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: It is inaccurate to assess blood glucose with glycated hemoglobin (HbA1c) in patients with diabetes and chronic kidney disease (CKD), and whether glycated albumin (GA) is better than HbA1c in these patients remains unclear. METHODS: We searched PubMed, Embase, Web of Science, Scopus, the Cochrane Library, and MEDLINE to July 2017 for studies that investigated the correlation between GA or HbA1c and the average glucose levels (AG) relevant to this theme. Statistical analysis was performed using RevMan5.3 and Stata12.0. The outcome was the correlation coefficient between GA or HbA1c and AG. For the first time, we made a comparison of GA and HbA1c in different CKD stages. RESULTS: A total of 24 studies with 3928 patients were included. Early stages of CKD refer to CKD stage 1 to 3. Advanced CKD refer to CKD stage 4 and 5 including patients receiving dialysis. The meta-analysis suggested that in early stages of CKD, the pooled R between GA and AG was 0.61 (95% CI = 0.49-0.73) and 0.71 (95% CI = 0.55-0.87) for HbA1c (P > 0.05). In advanced CKD patients, the pooled R between GA and AG was 0.57 (95% CI = 0.52-0.62), and 0.49 (95% CI = 0.45-0.52) for HbA1c (P = 0.0001). CONCLUSION: GA is superior to HbA1c in assessing blood glucose control in diabetes patients with advanced CKD.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Gan T, Liu X, Xu G, et al. Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients With Diabetes and CKD. Kidney Int Rep. 2017. PMID: 29854962. doi:10.1016/j.ekir.2017.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。